Altimmune ALT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$22.56M+17.5% | -$27.36M-43.9% | -$19.01M+14.1% | -$22.15M-13.1% | -$19.58M+15.6% | ||
| $23K-11.5% | $26K-3.7% | $27K-10.0% | $30K+3.4% | $29K-12.1% | ||
| $3.38M-31.6% | $4.94M+39.0% | $3.55M-0.3% | $3.57M-11.2% | $4.02M+19.7% | ||
| -$20.94M-7.7% | -$19.45M-63.5% | -$11.9M+38.5% | -$19.35M-14.9% | -$16.84M+7.8% | ||
| $21K+2,000% | $1K— | —— | —— | —— | ||
| -$3.69M+95.3% | -$79.16M+47.0% | -$149.32M-248% | $101.11M+2,082% | -$5.1M— | ||
| $78.47M-3.3% | $81.13M+106% | $39.35M-24.7% | $52.24M+53.1% | $34.12M+238% | ||
| $53.84M— | —— | —— | $134M+1,000% | $12.18M— | ||
| -$20.96M-7.8% | -$19.45M-63.5% | -$11.9M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Altimmune generate?
- Altimmune (ALT) generated -$71.6M in operating cash flow over the trailing twelve months.
- What is Altimmune's free cash flow?
- After $111.0K of capital expenditures, Altimmune's free cash flow was -$68.8M over the trailing twelve months, up 10.2% year over year.
- Where does Altimmune's cash flow data come from?
- Every line is extracted from Altimmune's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
